Trials / Unknown
UnknownNCT02750007
Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients
Open-label, Non-randomized, Weekly-dose Titration Study to Assess the Tolerability to HS-20004 in Type 2 (Diabetes Mellitus) Diabetic Patients
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted in China. The aim of this trial is to assess the tolerability to HS-20004 with titration administration in type 2 diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HS-20004 |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-01-01
- First posted
- 2016-04-25
- Last updated
- 2016-04-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02750007. Inclusion in this directory is not an endorsement.